The Sage Group Expands Team in North America – Dr. Christine T. Fischette Joins as New Executive Dir
London, England and New York, February 17 2020 - The Sage Group Inc. today announced that Dr. Christine T. Fischette will join the firm...
top of page
Sage Group News
OncoSec Announces Closing of the CGP/Sirtex Transaction
SAN DIEGO & PENNINGTON, N.J.--(BUSINESS WIRE)-- OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company...
The Sage Group Expands Team – Dr. Clarissa Ceruti Joins As Executive Director
London, England and New York, February 5 2020 - The Sage Group, Inc. today announced that Dr. Clarissa Ceruti will join the firm as an...
Sage Represents Trecondi® from Medac GmbH: Novel Product for Conditioning in AML and MDS Patients: O
Sage Group is working with medac GmbH who have developed Trecondi®, (Treosulfan), as a superior drug in conjunction with fludarabine...
Sage Represents BioHit Healthcare: Opportunity for Leadership in Nicotine-Free Smoking Cessation Usi
BioHit Healthcare has developed and gained approval in Europe for the Acetium® lozenge. This binds cigarette smoke-derived acetaldehyde...
G-MED, the Largest Online Global Medical Community Serving 1 Million Physicians and Growing!
London, 28 October 2019. G-Med is the largest Online Global Medical Community for >1,000,000 physicians, from over 120 countries...
OncoSec Announces $30 Million USD Strategic Investment at a Premium to Market by China Grand Pharmac
CGP Obtains a 12-Month Option to Offer to Acquire the Remaining Shares of OncoSec at the Greater of $4.50 Per Share or 110% of the Market...
WntResearch Increases Resources for Out-Licensing of Foxy-5
WntResearch and The Sage Group have initiated a collaboration to accelerate the process of identifying and engaging potential partners...
bottom of page